• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AMAG Pharmaceuticals Inc

+ Add to Watchlist

AMAG:US

17.7500 USD 0.2300 1.31%

As of 17:20:00 ET on 04/16/2014.

Snapshot for AMAG Pharmaceuticals Inc (AMAG)

Open: 17.6600 Day's Range: 17.2925 - 17.9660 Volume: 321,720
Previous Close: 17.5200 52wk Range: 16.4900 - 28.4172 1-Yr Rtn: -16.55%

Stock Chart for AMAG

No chart data available.
  • AMAG:US 17.7500
  • 1D
  • 1M
  • 1Y
17.5200
Interactive AMAG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMAG

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 31.0315
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1936
Est. EPS (USD) (12/2014) 0.5720
Est. PEG Ratio -
Market Cap (M USD) 386.95
Shares Outstanding (M) 21.80
30 Day Average Volume 542,658
Price/Book (mrq) 2.2416
Price/Sale (ttm) 4.7529
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMAG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMAG

AMAG Pharmaceuticals, Inc., a biopharmaceutical company, utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.

William K HeidenPresident/CEOScott A HolmesChief Acctg Officer/Treasurer
Frank E ThomasExec VP/COOChristopher G White "Chris"Senior VP/Chief Business Ofcr
More Company Profile & Key Executives for AMAG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil